Phase separation of p53 precedes aggregation and is affected by oncogenic mutations and ligandsElaine C. Petronilho, Jerson L. Silva, Murilo M. Pedrote et al.|Chemical Science|2021Cited by 108
p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cellsLuciana P. Rangel, Jerson L. Silva, Giulia D. S. Ferretti et al.|Journal of Biological Chemistry|2019Cited by 86
Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid OligomersMurilo M. Pedrote, Guilherme A. P. de Oliveira, Michelle F. Motta et al.|iScience|2020Cited by 82
Targeting Biomolecular Condensation and Protein Aggregation against CancerJerson L. Silva, Guilherme A. P. de Oliveira, Débora Foguel et al.|Chemical Reviews|2023Cited by 78
Anticancer Potential of Resveratrol, β-Lapachone and Their AnaloguesDanielly C. Ferraz da Costa, Jerson L. Silva, Luciana P. Rangel et al.|Molecules|2020Cited by 66